Johnson & Johnson Innovation United States

Johnson & Johnson (J&J) was founded in 1886 and is based in New Brunswick, NJ, with an Innovation Center in Cambridge, MA. The firm invests in a variety of fields within the life science sector, including medical devices. J&J’s medical device investments are highly varied in both size and structure; the structure may involve milestone payments, or may be an equity investment. J&J is interested in early stage medical device companies located globally.

Thorsten Melcher
New Ventures 

JVC Investment Partners United States

JVC Investment Partners is a private investment firm that was founded in 2000 and is based in Chicago, Illinois. The firm focuses on investments in the healthcare industry. The investment size can vary greatly and is very flexible depending on each company’s needs. The firm provides venture capital and growth capital to healthcare companies. For early-stage investments, the firm targets companies that provide solutions for hospital acquired infections, medication errors, healthcare system operational efficiency enhancements and cost reductions, and chronic disease management, and it typically invests equity or convertible preferred equity in post series A rounds. For growth investments, the firm targets companies with compelling products and strong position in niche markets and with an EBITDA in excess of $2 million. The firm primarily invests in companies based in US.

David Jonas
Founder, President & CEO 
Jonathan Jonas
Partner 

Lymo Investments

Lymo Investments is a multi-family venture fund based in Silicon Valley, CA. The firm is an active investor in the medical device sector, and is interested in opportunities worldwide. Initial investments are typically about $50,000 with the potential for follow-on investments totaling $500,000, and may be structured as equity or as debt. Lymo Ventures does not invest in seed rounds. In the recent past Lymo Investments has allocated new investments at a rate of approximately one every two months. The firm offers support and expertise to portfolio companies but does not seek a board seat.

Norm Gitis
Founder 

Mayo Clinic Ventures

Mayo Clinic Ventures serves to commercialize Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research and education at Mayo Clinic. The office has licensed hundreds of technologies in the fields of medical devices, diagnostics, therapeutics, and healthcare IT, and has focused efforts in technology-based ventures and start-ups.  Mayo Clinic Ventures also has a $20M venture capital fund which is used to spin out companies that are developing products based on Mayo Clinic research.

Kelly Krajnik
Business Development Manager 

Med Qiao Group LLC United States

Jean Yao, PhD, with 20+ years of extended experience in the areas of biology, medical research, and medical industry, has held various positions at Mayo Clinic and University of Minnesota. She funded Med Qiao Group LLC as for the Bridge between US and China in life science. Med Qiao provides business consulting services that include investment funding, market analysis, intellectual property protection, clinical trial arrangement, product approval application, China branch or division establishment as well as marketing, promotion, distribution and onsite manufacturing of medical products.

Jean Yao
Managing Partner 

MedForce

MedForce is the business accelerator arm of Almond Tree Capital and is based in Davis CA. The program makes seed and venture round investments in the form of equity or convertible loans. Investments may range up to $5 with the potential for follow-on investments. While Medforce?s investments are not restricted by region MedForce prefers to support companies based in Northern California or with ties to the region. The fund plans to invest in 2-4 companies in the next 6-9 months.
Cary Adams
CEO 
Christian Renaudin
Partner 

PBM Capital Group

PBM Capital is a hybrid family office and operating company based in Charlottesville Virginia with an additional office in New York City. The firm is funded and led by the successful life science entrepreneur Paul Manning who started and sold several companies in his career. The firm can make investments ranging from approximately $5 to $1 million into companies and due to its funding structure has no requirements for holding period or capital structure. The firm makes investments in the forms of equity controlling interest in-licensing MBO/LBO growth capital and is also willing to co-invest. The firm is looking for companies located around the globe and makes around 5-15 investments in a given year.
Jayson Rieger
SVP of Business Development & Portfolio Management 

RCT Ventures

RCT Ventures invests in early-stage life science companies including medical devices, drug discovery platforms, and research tools.

Paul Grand
Paul Grand
LinkedIn logo Managing Director 
BIO

Grand is responsible for sourcing RCT’s investments in medical devices and representing RCT on the boards of its portfolio companies.

Prior to joining RCT, Grand was co-founder and VP Operations of Imagine Pharmaceuticals, which developed a platform to selectively deliver therapeutics and other compounds across the blood brain barrier. He was also co-founder and CEO of MicroSurgeon, which developed a microwave thermal ablation device for the treatment of solid tumors.

Grand has extensive experience in new company formation and fund raising. Since 1990, he has built, operated, recruited management and raised financing for eight high technology, medical device and biotechnology companies. Grand also was a Managing Director for Fruition Ventures, a group of private equity investors focused primarily on tech companies.

Grand is actively involved in programs to encourage bio-entrepreneurship, innovation and commercialization of University technologies. He has lectured, judged business plans, and mentored students and scientists at numerous universities, including UCLA, Stanford, USC, and UCSF. Grand serves as an investment advisor to the LARTA NIH Commercialization Assistance Program for SBIR program awardees. He is on the Oversight Committees for the Coulter Translational Research Partnership Programs at USC and University of Washington. Grand is a reviewer for proof of concept and commercialization-focused funding programs for the University of California system-wide, USC, University of Utah and University of Colorado. 

Grand is a frequent panelist at biomedical conferences. He has spoken at more than 100 conferences, been featured in hundreds of articles in publications including Forbes, New York Times and Wall Street Journal and appeared as an expert on Bloomberg Television, CNN, and CNN/FN. Grand serves as Producer and Host for the MedTech Innovator competition that seeks to discover outstanding early-stage MedTech opportunities - http://medtechinnovator.com

Chad Souvignier
Managing Director 

Sand Hill Angels

Sand Hill Angels is an angel group that was founded in 2 and is headquartered in Sunnyvale California. The group focuses on investments in early-stage (from seed to series C) companies in the Life Sciences IT Internet and Clean Tech sectors. The group prefers to make equity and convertible notes investments and the typical investment size ranges from $.1million to $.5million. The group will consider syndicating with other investors for larger investments. The group will consider companies across the US.
Stephen Pollitt
Board Member Membership Chair 

Sanus Advisory Asia Singapore

Sanus Asia is a Singapore based advisory firm providing investment and transaction-related services across Asia with a focus on Healthcare and Life Sciences.

We work with investors and high potential companies to assist growth/development across Asia through capital raising and strategic/operational support.

We seek to identify high potential US/European Medtech and Digital Health companies with near-term commercialisation potential in Asia.

Will also consider earlier stage investments as a principal Angel investor if there is a strong Asian angle to the technology/business model.

Dr Ronald Ling
LinkedIn logo Managing Director